Article Text

Download PDFPDF
CASE REPORT
Gonadotropin-releasing hormone agonist against severe aggression in autism
  1. Robin M F van der Weiden1,
  2. Frans M Helmerhorst2,
  3. Tomas Eriksson3
  1. 1Department of Obsterics and Gynaecology, Sint Franciscus Gasthuis, Rotterdam, The Netherlands
  2. 2Department of Obstetrics and Gynaecology, Leids Universitair Medisch Centrum, Leiden, Zuid-Holland, The Netherlands
  3. 3The Biological Psychiatry Research Group, Department of Clinical Sciences, Lund University, Lund, Sweden
  1. Correspondence to Dr Robin M F van der Weiden, rmfvdwei{at}knmg.nl

Summary

Aggression in patients with autism spectrum disorder (ASD) presents an important therapeutic challenge. Conventional treatment appears to be inadequate in a number of cases. The occurrence of severe aggressive symptoms since the inception of adolescence in a male patient with ASD suggested a hormonal influence by androgens. Conventional treatment with antipsychotic and antiepileptic drugs and benzodiazepines was ineffective. A subcutaneous long-acting gonadotropin-releasing hormone agonist (GnRH agonist) injection was given on a monthly basis resulting in a substantial improvement in his aggressive behaviour and renewed socialisation.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.